Shannon KM - Search Results

1

Hyperactivation of protein kinase B and ERK have discrete effects on survival, proliferation, and cytokine expression in Nf1-deficient myeloid cells.

Donovan S, See W, Bonifas J, Stokoe D, Shannon KM. Donovan S, et al. Among authors: shannon km. Cancer Cell. 2002 Dec;2(6):507-14. doi: 10.1016/s1535-6108(02)00214-3. Cancer Cell. 2002. PMID: 12498719 Free article.

2

Genetic analysis is consistent with the hypothesis that NF1 limits myeloid cell growth through p21ras.

Kalra R, Paderanga DC, Olson K, Shannon KM. Kalra R, et al. Among authors: shannon km. Blood. 1994 Nov 15;84(10):3435-9. Blood. 1994. PMID: 7949098 Free article.

3

Molecular analysis at the NF1 locus in astrocytic brain tumors.

Jensen S, Paderanga DC, Chen P, Olson K, Edwards M, Iavorone A, Israel MA, Shannon K. Jensen S, et al. Cancer. 1995 Aug 15;76(4):674-7. doi: 10.1002/1097-0142(19950815)76:4<674::aid-cncr2820760421>3.0.co;2-4. Cancer. 1995. PMID: 8625164

4

Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders.

Side L, Taylor B, Cayouette M, Conner E, Thompson P, Luce M, Shannon K. Side L, et al. N Engl J Med. 1997 Jun 12;336(24):1713-20. doi: 10.1056/NEJM199706123362404. N Engl J Med. 1997. PMID: 9180088 Free article.

5

Role of the NF1 gene in leukemogenesis and myeloid growth control.

O'Marcaigh AS, Shannon KM. O'Marcaigh AS, et al. Among authors: shannon km. J Pediatr Hematol Oncol. 1997 Nov-Dec;19(6):551-4. doi: 10.1097/00043426-199711000-00015. J Pediatr Hematol Oncol. 1997. PMID: 9407945 Review. No abstract available.

6

Nf1 regulates hematopoietic progenitor cell growth and ras signaling in response to multiple cytokines.

Zhang YY, Vik TA, Ryder JW, Srour EF, Jacks T, Shannon K, Clapp DW. Zhang YY, et al. J Exp Med. 1998 Jun 1;187(11):1893-902. doi: 10.1084/jem.187.11.1893. J Exp Med. 1998. PMID: 9607929 Free PMC article.

7

Mutations of the NF1 gene in children with juvenile myelomonocytic leukemia without clinical evidence of neurofibromatosis, type 1.

Side LE, Emanuel PD, Taylor B, Franklin J, Thompson P, Castleberry RP, Shannon KM. Side LE, et al. Among authors: shannon km. Blood. 1998 Jul 1;92(1):267-72. Blood. 1998. PMID: 9639526 Free article.

8

Myeloid malignancies induced by alkylating agents in Nf1 mice.

Mahgoub N, Taylor BR, Le Beau MM, Gratiot M, Carlson KM, Atwater SK, Jacks T, Shannon KM. Mahgoub N, et al. Among authors: shannon km. Blood. 1999 Jun 1;93(11):3617-23. Blood. 1999. PMID: 10339466 Free article.

9

Hyperactive Ras as a therapeutic target in neurofibromatosis type 1.

Weiss B, Bollag G, Shannon K. Weiss B, et al. Am J Med Genet. 1999 Mar 26;89(1):14-22. Am J Med Genet. 1999. PMID: 10469432 Review.

10

In vitro and in vivo effects of a farnesyltransferase inhibitor on Nf1-deficient hematopoietic cells.

Mahgoub N, Taylor BR, Gratiot M, Kohl NE, Gibbs JB, Jacks T, Shannon KM. Mahgoub N, et al. Among authors: shannon km. Blood. 1999 Oct 1;94(7):2469-76. Blood. 1999. PMID: 10498620 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

360 results

Search Page

Filters